SNX2112 2 mg | 99.46%
TargetMol
SNX2112
Search Results
SNX2112 50 mg | 99.46%
TargetMol
SNX2112
SNX2112 5 mg | 99.46%
TargetMol
SNX2112
GW3965 hydrochloride 100 mg | Purity Not Available
TargetMol
GW3965 hydrochloride (GW3965 HCl) is an effective and specific LXR agonist for hLXRα/β (EC50: 190/30 nM).
More Information Supplier PageGW3965 hydrochloride
GW3965 hydrochloride 10 mg | Purity Not Available
TargetMol
GW3965 hydrochloride (GW3965 HCl) is an effective and specific LXR agonist for hLXRα/β (EC50: 190/30 nM).
More Information Supplier PageGW3965 hydrochloride
GW3965 hydrochloride 5 mg | Purity Not Available
TargetMol
GW3965 hydrochloride (GW3965 HCl) is an effective and specific LXR agonist for hLXRα/β (EC50: 190/30 nM).
More Information Supplier PageGW3965 hydrochloride
Allitinib tosylate 10 mg | Purity Not Available
TargetMol
AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, respectively.
More Information Supplier PageAllitinib tosylate
Allitinib tosylate 25 mg | Purity Not Available
TargetMol
AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, respectively.
More Information Supplier PageAllitinib tosylate
Allitinib tosylate 50 mg | Purity Not Available
TargetMol
AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, respectively.
More Information Supplier PageAllitinib tosylate
Allitinib tosylate 5 mg | Purity Not Available
TargetMol
AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, respectively.
More Information Supplier PageAllitinib tosylate